COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
In which patients with COVID-19 should we use monoclonal antibodies as prophylaxis or treatment? Hear expert insights on the timing and role of monoclonal antibody treatments for COVID-19 during the omicron era.
Decera Clinical Education Infectious Disease Podcast · Gregory Huhn MD MPHTM
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk of complications from acquiring COVID-19 or treatment of high-risk patients who have a mild to moderate COVID-19 infection. Listen as Gregory Huhn, MD, MPHTM, discusses when and how to use monoclonal antibodies including:
- Bebtelovimab
- Cilgavimab/tixagevimab
- Sotrovimab
Presenter:
Gregory Huhn, MD, MPHTM
Associate Professor
Department of Infectious Diseases
Rush University Medical Center
Senior Director of HIV Services
Department of Infectious Diseases
Cook County Health
Chicago, Illinois
Review the downloadable slidesets at:
https://bit.ly/3xOfu1A
Link to full program:
https://bit.ly/3EBdf38
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.